Tumor TP53 expression status, body mass index and prognosis in colorectal cancer
Teppei Morikawa(Dana-Farber Cancer Institute), Shuji Ogino(Broad Institute), Aya Kuchiba(Kanagawa University of Human Services), Charles S. Fuchs(University of Southern California), Yu Imamura(Japanese Foundation For Cancer Research), Jeffrey A. Meyerhardt(CancerCare), Xiaoyun Liao(Bristol-Myers Squibb (Germany)), Reiko Nishihara(Harvard University), Zhi Rong Qian(Dana-Farber Cancer Institute), Kaori Sato(Hokkaido University), Mai Yamauchi(Harvard University)
Cited by 59
Related Papers
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
|Cell Host & Microbe|2013|2.7k
Genomic analysis identifies association of <i>Fusobacterium</i> with colorectal carcinoma
|Genome Research|2011|2k
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer
|JAMA Oncology|2018|1.8k